The cannabis stock recently hit a new 52-week low.

Tilray's future extends beyond one regulatory hearing.

Paris city view (file photo) ...

Canadian marijuana 'n' American alcohol stock Tilray (NASDAQ: TLRY) stock crashed 19.4% through 10:10 a.m. ET Friday after confirming it will proceed with its 1-for-10 reverse stock split. On June 10, ...

Tilray Brands draws attention as cannabis policy developments approach and its diversified cannabis and beverage strategy ...

Cannabis stocks continue to benefit from Schedule III optimism, with investors now watching a June 29 hearing on broader marijuana rescheduling.

Tilray Brands has struggled to stay out of the red over the years, and that pattern may continue for the foreseeable future. The company's growth prospects are underwhelming. Tilray Brands (NASDAQ: ...

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading lower Tuesday morning, giving back a portion of the previous session’s explosive gains. The stock is experiencing a correction after surging over ...

What To Know: Cannabis stocks rallied last week following a report suggesting that President Donald Trump is expected to reclassify marijuana as a Schedule III drug. The proposed change would place ...

Tilray Brands (NASDAQ: TLRY), the Canadian marijuana stock, closed 22% higher yesterday after reporting a surprise profit for fiscal Q1. That's the good news. The bad news is that Tilray wasted no ...

Tilray will reverse split its stock 10-for-1 on Monday. The shares will resume trading Tuesday morning at a share price close to $8. On June 10, 2025, Tilray authorized Tilray to reverse-split its ...